Cargando…
A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma()
OBJECTIVES: Recurrence of hepatocellular carcinoma can arise from the primary tumor (“early recurrence”) or de novo from tumor formation in a cirrhotic environment (“late recurrence”). We aimed to develop one simple gene expression score applicable in both the tumor and the surrounding liver that ca...
Autores principales: | Dekervel, Jeroen, Popovic, Dusan, van Malenstein, Hannah, Windmolders, Petra, Heylen, Line, Libbrecht, Louis, Bulle, Ashenafi, De Moor, Bart, Van Cutsem, Eric, Nevens, Frederik, Verslype, Chris, van Pelt, Jos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833966/ https://www.ncbi.nlm.nih.gov/pubmed/27084430 http://dx.doi.org/10.1016/j.tranon.2016.02.003 |
Ejemplares similares
-
Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response
por: Dekervel, Jeroen, et al.
Publicado: (2016) -
Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts
por: Bulle, Ashenafi, et al.
Publicado: (2020) -
Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer
por: Bulle, Ashenafi, et al.
Publicado: (2020) -
Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease
por: Temmerman, Frederik, et al.
Publicado: (2017) -
DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
por: Galle, Eva, et al.
Publicado: (2020)